Endoxifen
Endoxifen Basic information
- Product Name:
- Endoxifen
- Synonyms:
-
- (Z)-4-Hydroxy-N-desmethyl Tamoxifen
- 4-[(1Z)-1-[4-[2-(Methylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]phenol
- Endoxifen
- Phenol, 4-[(1Z)-1-[4-[2-(MethylaMino)ethoxy]phenyl]-2-phenyl-1-butenyl]-
- (Z)-4-Hydroxy-N-desmethyl Tamoxifen (contains up to 10% E isomer) see D292043
- (Z)-4-Hydroxy-N-desmethyl Tamoxifen (contains up to 10% E isomer)
- (Z)-4-Hydroxy-N-DesMethyl TaMoxifen (Endoxifen)
- (Z)-Endoxifen
- CAS:
- 112093-28-4
- MF:
- C25H27NO2
- MW:
- 373.49
- Product Categories:
-
- Inhibitors
- Aromatics, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals
- Intermediates & Fine Chemicals
- Metabolites & Impurities
- Pharmaceuticals
- Aromatics
- Mol File:
- 112093-28-4.mol
Endoxifen Chemical Properties
- Melting point:
- 127-129°C
- Boiling point:
- 519.3±50.0 °C(Predicted)
- Density
- 1.099±0.06 g/cm3(Predicted)
- storage temp.
- Amber Vial, -86°C Freezer, Under Inert Atmosphere
- solubility
- DMSO : 50 mg/mL (133.87 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble)
- form
- Powder
- pka
- 10.36±0.15(Predicted)
- color
- White to off-white
- Stability:
- Light Sensitive, Temperature Sensitive
Endoxifen Usage And Synthesis
Chemical Properties
Off-White to Pink Solid
Uses
A novel active metabolite of the anti-cancer drug Tamoxifen. It showed potent ER binding property, blocked estrogen stimulated growth of breast cancer cell and half maximal inhibition of estrogen responsive gene expression in ER pos. human breast ca
Uses
A novel active metabolite of the anti-cancer drug Tamoxifen (T006000). It showed potent ER binding property, blocked estrogen stimulated growth of breast cancer cell and half maximal inhibition of estrogen responsive gene expression in ER pos. human breast cancer cell line.
Definition
ChEBI: 4-Hydroxy-N-desmethyltamoxifen is a stilbenoid.
Biological Activity
(Z)-Endoxifen (endoxifen) is an active tamoxifen metabolite generated via actions of cytochrome P450 (CYP) enzymes CYP3A4/5 and CYP2D6. Endoxifen is more potent than tamoxifen as a selective estrogen receptor modulator (SERM) both in vitro and in vivo with good pharmacokinetics and oral availability (∼80% MCF-7 tumor growth inhibition with 4-8 mg/kg/day endoxifen or 20 mg/kg/day tamoxifen in mice via p.o.). Endoxifen also exhibits 4-fold higher PKC inhibitory potency than tamoxifen and can overcome tamoxifen resistance due to cytochrome CYP2D6 polymorphism.
EndoxifenSupplier
- Tel
- sales@boylechem.com
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
- Tel
- 025-83697070
- info@chemlin.com.cn
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
Endoxifen(112093-28-4)Related Product Information
- Endoxifen HCl
- Tamoxifen Impurity 3
- 4-Benzyloxy β-Hydroxy TaMoxifen
- TaMoxifen DiMer
- 1-(4-(2-Dimethylamino)-2-ethoxyphenyl butanone
- N-Desmethyl-4-hydroxy Tamoxifen β-D-Glucuronide (E/Z Mixture)
- 4Hydroxy Tamoxifen
- Tamoxifen EP Impurity D
- (E)-4-Alloxycarboxyl Tamoxifen
- desdimethyltamoxifen
- TAMOXIFEN-N-OXIDE
- Droloxifene
- (E)-4-Acetoxy Tamoxifen
- N-Desmethyl Tamoxifen Methanethiosulfonate
- 2-[4-[(E)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethyl-ethanamine
- alpha-[4-[2-(dimethylamino)ethoxy]phenyl]-beta-ethyl-alpha-phenylphenethyl alcohol
- (E)-4-Hydroxy-N-desmethyl Tamoxifen
- 4-HYDROXYTAMOXIFEN